The CdCl2(C14H21N3O2) complex treatment group caused down-regulation of anti-apoptotic protein Bcl-2 by inducing anti-proliferative effects in the cancer control groups (47% and 43% respectively in groups treated with 25 mg/kg and 50 mg/kg of complex). The gene discussed is BCL2; the disease is cancer.